glp 1 vs 3 Part of a 3-Part Series; GLP-1 Medications for Weight Loss GLP-1 Medications for Weight Loss:

MADD is caused by deficiency of one of the two electron-transfer flavoproteins which transfer electrons from acyl-CoA dehydrogenases to Coenzyme Q in the respiratory chain: Electron Transfer Flavoprotein (ETF), encoded by ETFA and ETFB genes, and electron-transfer flavoprotein dehydrogenase (ETFDH), encoded by ETFDH [136]

Roughly 32% of tirzepatide-treated participants achieved 25% weight loss, versus 16% in the semaglutide arm

I fully agree that innovation in longevity medicine is important, but I wonder whether experimentation outside controlled research settings could put individuals at unnecessary risk

Langan RC, Goodbred AJ

The majority of people who start them dont stop taking them